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ABSTRACT: A review of literature related to community acquired Clostridium difficile-associated disease (CA-CDAD)
was conducted. Nine relevant studies were identified using the Cumulative Index to Nursing and Allied Health
(CINAHL) and MEDLINE-EBSCOhost databases. Clinical practice recommendations were obtained from the
Centers for Disease Control and Prevention. The studies provided information about epidemiology of infection due
to C. difficile in the community and interventions to reduce transmission. Multiple studies found underlying
gastrointestinal disorders and use of cephalosporin antibiotics to be a risk factor. Another risk factor was administration
of gastric acid suppressive drugs. No particular C. difficile strain was more likely to cause recurrence. Many positive
cases for CA-CDAD lacked traditional risk factors such as recent antibiotic exposure. To reduce transmission of CACDAD, it should be considered in the differential diagnosis of diarrhea. Clinicians should collect specimens for
culture based on patient history and current clinical presentation for patients with diarrhea. It is important that
patients be taught the proper hygiene and cleaning protocols to reduce transmission.
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INTRODUCTION
Clostridium difficile (C. difficile) is a gram positive, sporeforming toxin producing anaerobic rod bacteria that
results in millions of deaths per year (McFee &
Abdelsayed, 2009). Clostridium difficile-associated disease
(CDAD) is caused by the toxins released from the
bacteria C. difficile. The two toxins the bacteria produce
are toxin A and toxin B, which cause colonic dysfunction
and death (CDC, 2008). Symptoms of CDAD include
watery diarrhea, fever, loss of appetite, nausea and
abdominal pain (CDC, 2007). The clinical outcomes of
CDAD range from asymptomatic colonization to mild
diarrhea and more serious diseases such as
pseudomembranous colitis, toxic megacolon, bowel
perforation, sepsis, shock and death (Rupnik, Wilcox &
Gerding, 2009).
Risk factors associated with CDAD are increased age,
recent hospital admission, and previous use of antibiotics
and conditions that may affect colonic flora (Kuijper &
Van Dissel, 2008). Antibiotics are the primary risk factor
for CDAD because the antibiotics disrupt the normal
bowel flora and allow for C. difficile overgrowth.
Antibiotics associated with higher risk for CDAD are
clindamycin, cephalosporins, and floroquinolones
(McFee & Abdelsayed, 2009). Although most cases of
CDAD are associated with risk factors, many cases of
community acquired CDAD (CA-CDAD) are not.
(Kuijper & Van Dissel, 2008).
The Centers for Disease Control and Prevention (CDC)
differentiate CA-CDAD from hospital acquiredCDAD; CA-CDAD is diagnosed when the onset of
symptoms occurred while the patient was outside a
healthcare facility and the patient had not been
discharged from a healthcare facility within twelve weeks
prior to symptom onset; or the onset of symptoms
occurred within 48 hours after admission to a healthcare
facility and the patient had no prior stay in a healthcare
facility within twelve weeks before symptoms onset
(CDC, 2007).
In 2000, a new strain of C. difficile was identified as
North American pulsed-field 1 (NAP1). This new strain
produces an extra toxin and increased amounts of toxin
A and B. In addition, NAP1 causes increased morbidity
and mortality. Studies suggest that NAP1 may be the
most common strain in the community cases (CDC,
2008).

https://stars.library.ucf.edu/urj/vol5/iss1/4

PROBLEM
CDAD is no longer viewed simply as a complication of
hospital antibiotic treatment. What was once known
only as a hospital-acquired nosocomial infection is now
emerging in the community in large numbers. The
community CDAD infection rate in the United States
has been reported as 7.7 cases per 100,000 persons each
year (Rupnik, Wilcox & Gerding, 2009). The CDC
published similar findings in December 2005 of 7.6 cases
per 100,000 persons each year (CDC 2005).
CDAD has also been reported in healthy children,
pregnant women, and adults with no known risk factors.
In 2005, CDC researchers showed that 8 (24%) of the 22
low risk patients infected with CDAD had no direct
exposure to antibiotics, the leading risk factor (Kuijper &
Van Dissel, 2008). In addition, CDC researchers
expressed concerns in 2008 when a surveillance report in
Connecticut found a quarter of CDAD cases could not
be explained by traditional risk factors.
The CDC suggested that risk factors for acquiring
CDAD in the community include contact with a
contaminated
healthcare
environment
and/or
transmission from an infected person. C. difficile can be
transferred from a contaminated environment because
the spore form of C. difficile is heat stable and able to
survive harsh environments, such as the acidic human
stomach and surfaces ostensibly disinfected. Since most
disinfectants do not kill the spore, it is likely that C.
difficile is spread between healthcare providers and
patients indirectly and directly (McFee & Abdelsayed,
2009).
C. difficile can spread directly when a person touches a
surface contaminated with feces and then touches a
mucus membrane (Oriola, 2006). Equipment such as
commodes and thermometers may be reservoirs for the
bacteria. Indirect contact occurs when a health care
provider spreads the bacteria through hand contact from
one patient to another or contaminates a surface that is
then touched by someone else (Oriola, 2006).
Transmission can occur from an infected individual
when a person carrying C. difficile sheds the bacteria in
feces. In addition, alcohol based hand sanitizers do not
kill C. difficile (McFee & Abdelsayed, 2009).
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Jhung and his research team identified several human
cases of CDAD caused by toxinotype V strains of C.
difficile, which has been reported as a cause of epidemic
disease in neonatal pigs and calves ( Jhung et al., 2008).
Although no study has been conducted on interspecies
transmission of C. difficile, identification of the same
strain of C. difficile in both humans and animals suggests
a link ( Jhung et al., 2008).

agent. The environment is the conditions that influence
the interaction of the agent and the host, which includes
climatologic, biologic, social, and economic conditions.
Agent, host, and environment come together to form the
epidemiologic triangle of disease transmission (CDC,
2004).

Transmission of C. difficile may occur in three ways. The
first is exposure of humans and animals to the same
environment. The second is indirect contact through
contaminated produce, water or environment. Lastly,
transmission can occur through consumption of products
from food-producing animals ( Jhung et al., 2008).
Results from the study suggest toxinotype V C. difficile
may cause CA-CDAD ( Jhung et al., 2008)

Nine studies provided information about epidemiology
of infection due to C. difficile in the community and
interventions to reduce transmission. The studies were
conducted in a variety of settings including Sweden, the
United Kingdom, Australia, Toronto, and the United
States. Each study design was quantitative. Most studies
were retrospective case-control studies. Of the nine
studies, categories of the three different types of
epidemiologic factors emerged. These factors form the
epidemiologic triangle: host, agent, and environment.

PURPOSE

FINDINGS

The purpose of this research project is to provide a
comprehensive review of research findings about
community-acquired CDAD. Findings from this study
may show how clostridium difficile is spread from
healthcare workers to the community, and suggest
nursing interventions to reduce or prevent this
transmission. Therefore, the results of this study can be
applied to everyday practice to enhance patient outcomes.

HOST

METHOD

Hirschhorn, Trnka, Onderdonk, Lee, and Platt (1994),
identified 51 subjects in a retrospective study of CACDAD. The overall incidence rate was 7.7 cases per
1,000 persons per years. Twenty-two (43%) had a
concurrent illness. A total of 16% had inflammatory
bowel disease, and 8% had human immunodeficiency
virus (HIV) infection. Lastly, 4% had a malignancy.

A review of the research literature related to CA-CDAD
was conducted. Information was collected from the
Cumulative Index to Nursing and Allied Health
(CINAHL) and MEDLINE-EBSCOhost databases.
Clinical practice recommendations from the CDC
website were also used. Inclusion criteria for results
included peer-reviewed articles written in the English
language and both national and international studies.
Key terms are clostridium difficile, C. difficile and c-diff.
BACKGROUND
Disease transmission can be explained by the chain of
transmission. Disease occurs when an outside agent
capable of causing disease meets a host that is vulnerable
to the agent in an environment that allows the agent and
the host to interact (CDC, 2004). The agent is the entity
necessary to cause disease, typically a bacterium. The
host is the person who is susceptible to the effect of the
Published by STARS, 2011

In a study conducted in 1993 by Simor, Yake, and
Tsimidis, three host variables were identified and
associated with CDAD in a long term care facility. These
variables were the presence of a nasogastric or gastrostomy
tube (OR 6.5), urinary and fecal incontinence (OR 2.5),
and the presence of more than three underlying diseases
(OR 2.0).

McFarland, Clarridge, Beneda, and Raugi (2007), used a
conditional logistic model for all causes of CDAD,
including CA-CDAD. The model found two statistically
significant host risk factors: lower intestinal conditions
(OR 2.8) and number of comorbidities (OR 1.3).
AGENT
Noren et al. (2004) used PCR ribotyping to type the
different stool specimens obtained. There were 241
isolates of C. difficile from 241 patients and 89 isolates
from 54 patients with recurrences, totaling 330 isolates
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that underwent PCR ribotyping. Results found 53
distinct PCR ribotypes. The patterns of PCR ribotypes
of C. difficile were similar in the hospital and in the
community with the exception of type SE17. Of the 53
distinct PCR ribotypes, nine compromised 67% of
isolates from the hospital and 59% from the community.
SE17 was the most common ribotype and accounted for
22% of hospital acquired CDAD. Of the SE17 isolates
studied, 93% were identified as hospital acquired.
Therefore, SE17 is predominately a nosocomial infection.
A total of 208 of the 330 specimens tested were classified
as hospital acquired. The remaining 122 were community
acquired. Of the patients with CDAD, 68 experienced
recurrences. PCR ribotyping showed that in 90% of the
recurrent episodes, the isolate was the same ribotypes as
the initial ribotypes. The same nine major ribotypes that
caused the initial infection were associated with
recurrence. Therefore, no particular C. difficile strain was
more likely to cause recurrence (Noren et al., 2004).
ENVIRONMENT
In 1986, a study was undertaken by Riley, Wymer,
Bamford and Bowman that demonstrated that several
antibiotics were the central cause of CA-CDAD. The
antibiotic most associated with the disease was
clindamycin.
A prospective nationwide study of CDAD was carried
out in Sweden during 1995. KarlstrÖm et al. found that
28% of all cases of CDAD involved no hospitalization
within the preceding four weeks to diagnosis, defined as
CA-CDAD (1998). Of the cases defined as community
acquired, the majority were diagnosed in primary care.
In addition, 88% had taken antibiotics in the previous six
weeks (KarlstrÖm et al., 1998).
In 2000, Levy et al. identified two cephalosporins with
increased risk for developing CDAD in the ambulatory
care setting, cephalexin (OR 7.5, CI 1.8-34.7) and
cefixime (OR 6.4, CI 1.2-39.0).
Dial, Delaney, Barkun, and Suissa (2005) conducted a
study to determine if gastric acid suppressive drugs
increased the risk for CA-CDAD. A total of 1672
patients were identified as having CDAD, and of those,
1233 (74%) infections were considered community
acquired. There was a noteworthy increase in the rate of
cases diagnosed as community acquired, from less than 1
per 100,000 persons in 1994, to 22 per 100,000 in 2004.
Also, records showed from 1994 to 2004 a decrease in
https://stars.library.ucf.edu/urj/vol5/iss1/4

the number of antibiotic prescriptions and an increase in
proton pump inhibitor prescriptions. The researchers
found exposure to antibiotics as a risk factor for all cases
of CDAD. In a second analysis examining only CACDAD, researchers found proton pump inhibitor
exposure to have an adjusted rate ratio of 2.9 (CI 2.43.4) and H2-receptor antagonists to have a adjusted rate
ratio of 2.0 (CI 1.6-2.7). Therefore, there is an increased
risk for CA-CDAD with gastric acid suppressive drugs.
Also, in the 90 days prior to diagnosis, only 37% of the
cases had antibiotic exposure (Dial, Delaney, Barkin &
Suissa, 2005).
In a study conducted by McFarland, Clarridge, Beneda,
and Raugi (2007), 184 patients were diagnosed with
CDAD. Twenty patients of the 184 patients (11%) had
community acquired cases. More than half of the
patients with CA-CDAD had no prior antibiotic
exposure.
Also, the patients with CA-CDAD
experienced shorter duration of hospitalization and
lower mortality. The majority of the patients with
CDAD were treated with either metronidazole or
vancomycin. Drugs considered to be high risk factors of
developing CA-CDAD were clindamycin (OR 29.9)
and penicillin (OR 4.1). Also, taking multiple antibiotics
during the same time period increases risk for CACDAD (OR 1.4).
Wilcox, Mooney, Bendall, Settle, and Fawley (2008)
found several risk factors for developing CA-CDAD.
Exposure to antibiotics in the previous four weeks,
particularly multiple agents (p < 0.001), aminopenicillins
(p < 0.05), and oral cephalosporins (p < 0.05), were
significantly more frequent among cases than controls.
Hospitalization in the preceding six months was
significantly associated with CA-CDAD (45% versus
23%; p = 0.022). Almost half the cases had not received
antibiotic therapy in the month before C. difficile
detection, and approximately one third experienced
neither exposure to antibiotics nor recent hospitalization.
Contact with infants younger than two years old was also
considered a risk factor (14% versus 2%; p = 0.02).
DISCUSSION
Host
Simor, Yake, and Tsimidis (1993) found urinary and fecal
incontinence to be a risk factor for CA-CDAD. The risk
for infection may be due to an increase risk for fecal-oral
transmission. Results from pulse-field gel electrophoresis
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showed diversity among the strains carried by each
resident, suggesting the origin of infection is endogenous
rather than exogenous. Exogenous bacteria are introduced
internally to the gastrointestinal tract from the external
world. Endogenous bacteria are part of our body’s
normal flora.
In their study, which was similar in form to others,
Hirschhorn, Trnka, Onderdonk, Lee and Platt (1994)
found underlying disease and gastrointestinal conditions
such as inflammatory bowel disease to be a risk factor.
Both the number of comorbidities and the presence of
lower intestinal conditions were significant risk factors
for CDAD in a study conducted by McFarland,
Clarridge, Beneda, and Raugi (2007). These conditions
affect normal intestinal microflora similarly to antibiotics,
thereby increasing the risk for CDAD. People who have
inflammatory bowel disease have a disrupted colonic
flora. Lower intestinal conditions such as polyps may
alter the body’s normal ability to resist overgrowth
(McFarland, Clarridge, Beneda & Raugi, 2007).
Agent
Noren et al. (2004) found that CDAD is usually due to
endogenous infection. Apart from type SE17 strain
being mostly nosocomial, no C. difficile strain had
superior transmission ability or ability to cause recurrent
infection.
Environment
KarlstrÖm et al. (1998) reported an increase in the
number of CDAD. A total of 5, 133 CDAD cases were
recorded in 1995, compared to 86 in 1978. A possible
explanation for the increase is an increase in the number
of broad-spectrum cephalosporins prescribed in Sweden
during the study timeframe. Most of the patients with
CA-CDAD had taken antibiotics prior to diagnosis.
Dial, Delaney, Barkun, and Suissa (2005) performed a
large population study and found gastric acid suppressive
drugs were associated with an increased risk of CACDAD. There was a greater association with proton
pump inhibitors and CA-CDAD than H2-receptor
antagonists. These results may rise because the degree of
acid suppression is greater in proton pump inhibitors
than H2-receptor antagonists. Furthermore, a decrease
in gastric acid is known to be a risk factor for acquiring
other causes of diarrhea, such as cholera. In addition,
Published by STARS, 2011

when gastric acid is suppressed, there is an association of
colonization of the upper gastrointestinal tract, which is
normally sterile (Dial, Delaney, Barkin & Suissa, 2005).
Although antibiotic exposure is a major risk factor for
the disease, there is a significant number of CA-CDAD
with no history of antibiotic use 90 days prior to
diagnosis.
CA-CDAD with no history of antibiotics is a trend seen
in most published studies. Therefore, reliance on
antibiotic history could contribute to missed diagnoses.
However, exposure
to
antibiotics, especially
cephalosporins, are still a leading risk factor.
LIMITATIONS
In this integrated review of the research literature, there
were a number of limitations. Most studies were
retrospective studies that relied on medical records for
data. Therefore, the studies were limited by the fact that
primary care medical records were not available. Also,
emergency department records did not always state
previous antibiotic use. Another limitation was a lack of
access to medical records from other care providers.
Some patients may not have sought medical care in some
instances, or physicians may not have considered or
recorded the diagnosis of diarrhea in the medical record.
In general practice, most laboratories only performed
testing based on requests from the physicians for
community acquired specimens; therefore, it is likely that
only symptomatic patients were tested.
One study (Levy et al., 2000) looked at medical claims
rather than medical records. This limits the amount of
information received. For example, the medical claim
dose not report the dose or duration of antibiotic
prescribed.
The laboratory tests performed to detect C. difficile toxins
could also be a limitation. Each study qualified
community acquired disease versus hospital acquired
disease differently. In addition, each test has the potential
to give false results. Furthermore, C. difficile isolates that
were not typed could not be studied for different C.
difficile variants.
A majority of the nine studies examined had a large
population pool. However, two did not (Simor, Yake &
Tsimidis and McFarland, Clarridge, Beneda & Raugi).
These two studies cannot be generalized because both
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the long term care population and veterans population
respectively consists of mostly older adults with a
significant number of comorbidities.
RECOMMENDATIONS FOR NURSING
Education
Public health nurses draw from the core competencies
for nursing in designing and implementing communitybased interventions. The core competencies should be
used to guide baccalaureate nursing curricula. To
strengthen nursing curricula, one key core competency is
awareness of the assessment: the skill needed to evaluate
the integrity and comparability of data and identify gaps
in data sources. Another core competency of importance
is policy development awareness of the baccalaureate
nurse to translate policy into organizational plans,
structures, and programs. It is important to evaluate data
from research studies to determine their integrity because
not all studies should be used to change policy and
procedures. Policy development is vital to improve
patient outcomes and help eliminate communicable
diseases (Association of Community Health Nursing
Educators, 2003).
Pratice
The CDC recommends that clinicians teach their
patients to limit transmission and inquire about similar
cases in household members and close contacts. It is
important that patients be taught proper hygiene and
cleaning protocols to reduce transmission. To reduce
transmission of CA-CDAD, CDAD should be
considered in the differential diagnosis of diarrhea.
Clinicians should collect specimens for culture based on
patient history and current clinical presentation for
patients with diarrhea. Lastly, clinicians should routinely
ask about similar cases in household members and close
contacts.
Research
Future research should include a standard definition of
CA-CDAD. More research is needed to look at high risk
populations, such as pregnant women, infants, and
children. Further research should focus on different
types of study.
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